Why SITSA Act will actually move the needle backward on the opioid crisis
The Federal Analogue Act, passed way back in 1986, already created substantial authority for prosecutors to treat synthetic analogs the same way as they would treat the drugs they resemble. Additionally, in November 2017, the Drug Enforcement Administration established a new order that automatically scheduled any fentanyl analog into the same legal category as fentanyl. In other words, the supposed benefit of imposing the SITSA Act has already been addressed by multiple other governmental actions.
Not only has the DEA already scheduled existing fentanyl analogs, but it’s also covered its bases for any that may eventually be invented … Nonetheless, Representative Jim Sensenbrenner (R-WI), one of the bill’s co-sponsors, expressed the same misguided attitude in a press release about the SITSA Act, saying that it “modernizes the Controlled Substance Act by adding a new schedule, Schedule A, to the five existing schedules,” as well as immediately scheduling 13 fentanyl analogs. He fails to point out that the DEA already has the authority to schedule these analogs … But perhaps more importantly, it would add to the harmful trend of criminalizing drug use by specifying mandatory sentences for drug offenders, a practice that has been shown not to help stem the flow of drugs. In an open letter to Congress, members of Human Rights Watch, the ACLU, the NAACP, and over a dozen other organizations argue that the SITSA Act is a step backward in drug policy.
Original Article (Inverse):
Why SITSA Act Will Actually Move the Needle Backward on the Opioid Crisis
Artwork Fair Use: eric molina